| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2663765 | Journal of Pediatric Nursing | 2014 | 7 Pages |
Abstract
The study aim was to evaluate present practice of maintaining PICC line patency in pediatric heart failure patients receiving continuous inotropes by comparing one cohort receiving low dose continuous heparin with one receiving no heparin. A case control retrospective chart review compared the two cohorts on duration of patency (measured in days) and need for thrombolytic agents. Median duration of patency for the heparin group was 24 days versus 16 days for the no heparin group (p = 0.07). Use of thrombolytic agents was 28% in the heparin group compared to 50% in the no heparin group (p = 0.08). Although not statistically significant, findings were clinically significant and supportive of current practice.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Maeve Giangregorio, Sandra Mott, Elizabeth Tong, Sonia Handa, Kimberlee Gauvreau, Jean Anne Connor,